排序方式: 共有54条查询结果,搜索用时 15 毫秒
1.
Corbett EL Makamure B Cheung YB Dauya E Matambo R Bandason T Munyati SS Mason PR Butterworth AE Hayes RJ 《AIDS (London, England)》2007,21(4):483-489
OBJECTIVE: To investigate HIV incidence during a trial of two voluntary counselling and testing (VCT) strategies. Counselling may promote beneficial behavioural change, although knowledge of negative status does not appear to contribute further benefit. DESIGN: The parent cluster-randomized trial demonstrated much greater uptake of VCT when counselling and rapid testing were available on-site (intensive VCT) than through pre-paid vouchers to an external provider (standard VCT). Anonymous HIV tests had been requested from all employees at enrolment and after 2 years intervention. METHODS: The study setting was 22 businesses in Harare, Zimbabwe. Participants were 3146 HIV-negative individuals remaining in employment at the end of intervention, of whom 2966 (94.3%) consented to repeat testing. VCT linked to basic HIV care was provided and the main outcome measures were HIV incidence under each study arm, as a retrospective secondary analysis. RESULTS: Mean VCT uptake in this cohort was 70.7 and 5.2%, respectively, in the intensive and standard arms. Crude HIV incidence was 1.21 per 100 person-years, with non-significantly higher rates in the intensive VCT arm [mean site incidence 1.37 and 0.95 per 100 person-years, respectively; adjusted rate ratio 1.49 (95% confidence interval 0.79-2.80). CONCLUSIONS: Highly acceptable VCT did not reduce HIV incidence in this predominantly male cohort. HIV incidence was highest in the high uptake VCT arm, lending support to a US trial in which rapid testing appeared to have adverse behavioural consequences in some HIV-negative clients. Careful comparison of outcomes under different counselling and testing strategies is needed to maximize HIV prevention from global scale-up of VCT. 相似文献
2.
Merika K HeftitArthur F Preshaw PM 《The European journal of prosthodontics and restorative dentistry》2006,14(1):38-41
This study compares two commercially-available products for treating dentine sensitivity, Duraphat, a fluoride varnish, and SuperSeal, an oxalate preparation. 48 patients with dentine sensitivity were recruited. Sensitivity was assessed by visual analogue scales (VAS) to record pain following stimulation of exposed dentine surfaces by tactile stimulus (sharp probe at 60g force), thermal stimulus (ethyl chloride) and evaporative stimulus (air drying). Patients were randomised to treatment with either Duraphat or SuperSeal. After 4 weeks, sensitivity assessments were repeated. Both treatments resulted in statistically significant reductions in VAS scores for all stimuli (P<0.05). However, analysis of covariance failed to identify statistically significant differences in the magnitude of reductions in sensitivity achieved by each of the products (P>0.05). The treatments had similar efficacy and both can be considered effective therapies for treating dentine sensitivity. 相似文献
3.
Despite advances in research and treatment modalities, colorectal cancer still accounts for around half a million deaths yearly worldwide. Traditional and even newer pharmaceutical therapeutic regimens are limited in terms of tolerance, efficacy and cross-resistance. Additional non-cross resistant therapies with non-overlapping toxicities are needed to improve the outcome for patients with colorectal cancer. Cancer vaccines, designed to activate immune effectors (T-cells and antibodies) to prevent recurrence or treat advanced cancers, have now demonstrated clinical benefit in prostate cancer and lymphoma. Because immune effector infiltration into colon tumours is associated with improved clinical outcome, vaccines intended to activate immune responses against colon cancer have generated significant interest. This review discusses data supportive of the immune responsiveness of colorectal cancer, as well as the current status of colon cancer vaccines under development including those based on whole tumour cells or lysates, peptide or protein antigens, anti-idiotype antibodies, viral vectors, and dendritic cells. We also discuss challenges to colon cancer vaccine development, such as tumour associated mechanisms for immune evasion, and how future strategies may address these challenges. 相似文献
4.
Chan PK Luk AC Park JS Smith-McCune KK Palefsky JM Konno R Giovannelli L Coutlée F Hibbitts S Chu TY Settheetham-Ishida W Picconi MA Ferrera A De Marco F Woo YL Raiol T Piña-Sánchez P Cheung JL Bae JH Chirenje MZ Magure T Moscicki AB Fiander AN Di Stefano R Cheung TH Yu MM Tsui SK Pim D Banks L 《The Journal of infectious diseases》2011,203(11):1565-1573
5.
6.
Sacks Emma Masvawure Tsitsi B. Atuyambe Lynn M. Neema Stella Macwan’gi Mubiana Simbaya Joseph Kruk Margaret 《Maternal and child health journal》2017,21(3):599-606
Maternal and Child Health Journal - Objectives The objective of this study was to examine experiences with, and barriers to, accessing postnatal care services, in the context of a maternal health... 相似文献
7.
Katharina Kranzer John Bradley Joseph Musaazi Mary Nyathi Hilary Gunguwo Wedu Ndebele Mark Dixon Mbongeni Ndhlovu Andrea Rehman Palwasha Khan Florian Vogt Tsitsi Apollo Rashida Abbas Ferrand 《Journal of the International AIDS Society》2017,20(1)
Introduction : Globally, increasing numbers of HIV‐infected children are reaching adolescence due to antiretroviral therapy (ART). We investigated rates of loss‐to‐follow‐up (LTFU) from HIV care services among children as they transition from childhood through adolescence. Methods : Individuals aged 5–19 years initiated on ART in a public‐sector HIV clinic in Bulawayo, Zimbabwe, between 2005 and 2009 were included in a retrospective cohort study. Participants were categorized into narrow age‐bands namely: 5–9 (children), 10–14 (young adolescents) and 15–19 (older adolescents). The effect of age at ART initiation, current age (using a time‐updated Lexis expansion) and transitioning from one age group to the next on LTFU was estimated using Poisson regression. Results : Of 2273 participants, 1013, 875 and 385 initiated ART aged 5–9, 10–14 and 15–19 years, respectively. Unlike those starting ART as children, individuals starting ART as young adolescents had higher LTFU rates after moving to the older adolescent age‐band (Adjusted rate ratio (ARR) 1.54; 95% CI: 0.94–2.55) and similarly, older adolescents had higher LTFU rates after transitioning to being young adults (ARR 1.79; 95% CI: 1.05–3.07). In older adolescents, the LTFU rate among those who started ART in that age‐band was higher compared to the rate among those starting ART at a younger age (ARR = 1.70; 95% CI: 1.05, 2.77). This however did not hold true for other age‐groups. Conclusions : Adolescents had higher rates of LTFU compared to other age‐groups, with older adolescents at particularly high risk in all analyses. Age‐updated analyses that examine movement across narrow age‐bands are paramount in understanding how developmental heterogeneity in children affects HIV outcomes. 相似文献
8.
9.
10.
Ferrand RA Weiss HA Nathoo K Ndhlovu CE Mungofa S Munyati S Bandason T Gibb DM Corbett EL 《Tropical medicine & international health : TM & IH》2011,16(3):349-355
Objective To present an algorithm for primary‐care health workers for identifying HIV‐infected adolescents in populations at high risk through mother‐to‐child transmission. Methods Five hundred and six adolescent (10–18 years) attendees to two primary care clinics in Harare, Zimbabwe, were recruited. A randomly extracted ‘training’ data set (n = 251) was used to generate an algorithm using variables identified as associated with HIV through multivariable logistic regression. Performance characteristics of the algorithm were evaluated in the remaining (‘test’) records (n = 255) at different HIV prevalence rates. Results HIV prevalence was 17%, and infection was independently associated with client‐reported orphanhood, past hospitalization, skin problems, presenting with sexually transmitted infection and poor functional ability. Classifying adolescents as requiring HIV testing if they reported >1 of these five criteria had 74% sensitivity and 80% specificity for HIV, with the algorithm correctly predicting the HIV status of 79% of participants. In low‐HIV‐prevalence settings (<2%), the algorithm would have a high negative predictive value (≥99.5%) and result in an estimated 60% decrease in the number of people needing to test to identify one HIV‐infected individual, compared with universal testing. Conclusions Our simple algorithm can identify which individuals are likely to be HIV infected with sufficient accuracy to provide a screening tool for use in settings not already implementing universal testing policies among this age‐group, for example immigrants to low‐HIV‐prevalence countries. 相似文献